˅
Analytical & Technical Leadership
From early-phase feasibility to final design requirements, we can meet the needs of challenging drug formulations.
- Feasibility and early-phase development capabilities
- Human tolerability and human factors studies
- Proven ability to develop challenging drug formulations
- Preclinical and clinical capabilities
- Regulatory leadership and expert data analysis to support submissions and filings
˅
Innovative Devices
Refined over several device generations, Kindeva’s microstructured systems are designed for consistent intradermal delivery of vaccines and biologics. Our patient-friendly technology is available in two formats, providing an option of delivery routes to enable your commercial success.
- Solid Microstructures – offers potential for increased immunogenicity, dose sparing, cold chain elimination, and increased patient convenience via self-administration
- Hollow Microstructures – offers reproducible intradermal delivery of a wide range of viscosities
˅
Operational Excellence
With sophisticated project management, rigorous quality processes, manufacturing excellence, and cGMP facilities, Kindeva supports a reliable supply chain for your program.
- Automated Array Molding and Packaging
- Aseptic Array Coating for Solid Microstructures
- Qualified Equipment for Device Assembly Process
- Manufacturing capability for Preclinical, Clinical, and Scale-up Activities